Empresa Altimmune Inc Nasdaq
Acciones
US02155H1014
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Treatments for Various Diseases and Disorders, and Vaccines
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -726,47 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -726,47 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 30/11/18 |
Director of Finance/CFO | 66 | 31/12/21 | |
Anthony Blandin
CMP | Compliance Officer | - | 01/02/22 |
M. Roberts
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/12/12 |
Bertrand Georges
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/15 |
M. Harris
CTO | Chief Tech/Sci/R&D Officer | 71 | 09/09/19 |
Karen Smith
PRN | Corporate Officer/Principal | - | 01/09/20 |
Andrew Shutterly
AUD | Comptroller/Controller/Auditor | - | 01/10/20 |
56 | - | ||
Raymond Jordt
PRN | Corporate Officer/Principal | 52 | 01/01/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Mitchel Sayare
CHM | Chairman | 76 | 01/04/10 |
Mack Gill
BRD | Director/Board Member | 72 | 01/08/04 |
Philip Hodges
BRD | Director/Board Member | 56 | 01/09/03 |
Vipin K. Garg
CEO | Chief Executive Officer | 67 | 30/11/18 |
David Drutz
BRD | Director/Board Member | 86 | 01/01/10 |
Wayne Pisano
BRD | Director/Board Member | 69 | 30/08/18 |
Diane Jorkasky
BRD | Director/Board Member | 72 | 11/05/20 |
Catherine Sohn
BRD | Director/Board Member | 71 | 23/03/23 |
Klaus Schafer
BRD | Director/Board Member | 74 | 01/07/12 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 70 902 191 | 70 351 925 ( 99,22 %) | 0 | 99,22 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+11,91 % | 118 mil M | |
+11,60 % | 106 mil M | |
-4,68 % | 24,28 mil M | |
-0,82 % | 21,96 mil M | |
-10,12 % | 18,16 mil M | |
-42,12 % | 16,37 mil M | |
-17,47 % | 15,56 mil M | |
+2,77 % | 13,63 mil M | |
+34,58 % | 12,27 mil M |